Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 12/20 | 0.73 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10649922 | 0.98 | SIGMAR1 (0.77) | SIGMAR1L3MBTL1MEN1KMT2A | |
| SCHEMBL22251830 | 0.98 | SIGMAR1 (0.77) | SIGMAR1L3MBTL1MEN1KMT2A | |
| SCHEMBL9324795 | 0.98 | SIGMAR1 (0.77) | SIGMAR1L3MBTL1MEN1KMT2A | |
| SCHEMBL3441609 | 0.94 | SIGMAR1 (0.75) | SIGMAR1MEN1KMT2A | |
| Iodide SCHEMBL31425558 | 0.92 | SIGMAR1 (0.72) | SIGMAR1MEN1KMT2A | |
| SCHEMBL4344582 | 0.92 | SIGMAR1 (0.72) | SIGMAR1MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL8508325 | 0.92 | SIGMAR1 (0.72) | SIGMAR1MEN1KMT2A | |
| Sulfuric Acid SCHEMBL10335410 | 0.91 | MEN1 (0.63) | SIGMAR1L3MBTL1MEN1KMT2A | |
| SCHEMBL11699466 | 0.89 | SIGMAR1 (0.58) | SIGMAR1L3MBTL1 | |
| SCHEMBL7165896 | 0.88 | TAAR1 (0.61) | SIGMAR1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210292353-A1 | INORGANIC-ORGANIC HYBRID COMPOUNDS INCLUDING ORGANIC PLATINUM-CONTAINING ANIONS, FOR USE IN MEDICINE | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2021-09-23 | — | — | US | claimed |
| CN-1343024-A | Organic amine used as additive in electrochemical battery | MERCK PATENT GMBH (DE) | 2002-04-03 | — | — | CN | claimed |
| EP-1187244-A2 | Organic amines as additives for electrochemical cells | MERCK PATENT GmbH (DE) | 2002-03-13 | — | — | EP | claimed |
| US-20100323098-A1 | ELECTRODE MATERIAL FOR RECHARGEABLE LITHIUM BATTERY, ELECTRODE STRUCTURAL BODY COMPRISING SAID ELECTRODE MATERIAL, RECHARGEABLE LITHIUM BATTERY HAVING SAID ELECTRODE STRUCTURAL BODY, PROCESS FOR THE PRODUCTION OF SAID ELECTRODE STRUCTURAL BODY, AND PROCESS FOR THE PRODUCTION OF SAID RECHARGEABLE LITHIUM BATTERY | CANON KABUSHIKI KAISHA (JP) | 2010-12-23 | — | — | US | disclosed |
| US-7803290-B2 | Electrode material for rechargeable lithium battery, electrode structural body comprising said electrode material, rechargeable lithium battery having said electrode structural body, process for the production of said electrode structural body, and process for the production of said rechargeable lithium battery | CANON KABUSHIKI KAISHA (JP) | 2010-09-28 | — | — | US | disclosed |
| US-7566734-B2 | Imidazolyl derivatives | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES, S.A.S. (FR) | 2009-07-28 | — | — | US | disclosed |
| US-7504391-B2 | Selective D1/D5 receptor antagonists for the treatment of obesity and CNS disorders | SCHERING CORPORATION (US) | 2009-03-17 | — | — | US | disclosed |
| WO-2008149053-A1 | BICYCL0 [2. 2. 1] HE PT- 2-YLAMINE DERIVATES AND THEIR USE | ARGENTA DISCOVERY LTD. (GB) | 2008-12-11 | — | — | WO | disclosed |
| US-20080090152-A1 | Electrode material for rechargeable lithium battery, electrode structural body comprising said electrode material, rechargeable lithium battery having said electrode structural body, process for the production of said electrode structual body, and process for the production of said rechargeable lithium battery | CANON KABUSHIKI KAISHA (JP) | 2008-04-17 | — | — | US | disclosed |
| US-7316792-B2 | Electrode material for rechargeable lithium battery and electrode structural body comprising said electrode material | CANON KABUSHIKI KAISHA (JP) | 2008-01-08 | — | — | US | disclosed |
| WO-2007054971-A2 | USE OF ACID SCAVENGERS IN REMOVAL OF PROTONS (ACIDITY) OF THE REACTION MASS DURING CHLORINATION OF SUCROSE-6- ACETATE | PHARMED MEDICARE PVT. LTD. (IN) | 2007-05-18 | — | — | WO | disclosed |
| US-20070032653-A1 | N-{1-(4-(3-bromophenyl)-1H-imidazol-2-yl)-5-methylhexyl}-N-cyclohexylamine; agonists or antagonists of somatostatin receptors; acromegaly, restenosis, Crohn's disease, systemic sclerosis, external and internal pancreatic pseudocysts and ascites, nesidoblastosis, hyperinsulinism, gastrinoma, etc. | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES, S.A.S. (FR) | 2007-02-08 | — | — | US | disclosed |
| US-7141187-B2 | Electrode material for rechargeable lithium battery, electrode structural body comprising said electrode material, rechargeable lithium battery having said electrode structural body, process for the production of said electrode structural body, and process for the production of said rechargeable lithium battery | CANON KABUSHIKI KAISHA (JP) | 2006-11-28 | — | — | US | disclosed |
| US-20060237697-A1 | Electrode material for rechargeable lithium battery, electrode structural body comprising said electrode material, rechargeable lithium battery having said electrode structural body, process for the production of said electrode structural body, and process for the production of said rechargeable lithium battery | CANON KABUSHIKI KAISHA (JP) | 2006-10-26 | — | — | US | disclosed |
| US-20030157407-A1 | Electrode material for rechargeable lithium battery, electrode structural body comprising said electrode material, rechargeable lithium battery having said electrode structural body, process for the production of said electrode structural body, and process for the production of said rechargeable lithium battery | CANON KABUSHIKI KAISHA (JP) | 2003-08-21 | — | — | US | disclosed |
| CN-1343024-A | Organic amine used as additive in electrochemical battery | MERCK PATENT GMBH (DE) | 2002-04-03 | — | — | CN | disclosed |
| EP-1187244-A2 | Organic amines as additives for electrochemical cells | MERCK PATENT GmbH (DE) | 2002-03-13 | — | — | EP | disclosed |
| US-4987132-A | PLATELET ACTIVATING FACTOR ANTAGONISTS | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1991-01-22 | — | — | US | disclosed |
| EP-0279681-A2 | Saturated heterocyclic carboxamide derivatives | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 1988-08-24 | — | — | EP | disclosed |
| EP-0002604-A1 | Quaternary ammonium salts, and their formulations and preparation | ELI LILLY AND COMPANY (US) | 1979-06-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070032653-A1 | N-{1-(4-(3-bromophenyl)-1H-imidazol-2-yl)-5-methylhexyl}-N-cyclohexylamine; agonists or antagonists of somatostatin receptors; acromegaly, restenosis, Crohn's disease, systemic sclerosis, external and internal pancreatic pseudocysts and ascites, nesidoblastosis, hyperinsulinism, gastrinoma, etc. | GHSR, IGF1R, GIPR | SIGMAR1 505/4885L3MBTL1 2514/4885MEN1 41/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.